Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.44 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL954267 | 0.84 | TAAR1 (0.53) | TAAR1TSHRLMNAADRA1D | |
| SCHEMBL285224 | 0.77 | TERT (0.59) | TAAR1TERTTSHRCYP2D6 | |
| SCHEMBL2030841 | 0.74 | TAAR1 (0.71) | TAAR1TSHR | |
| SCHEMBL5548987 | 0.71 | TERT (0.43) | TAAR1TERTCYP2D6 | |
| SCHEMBL5757254 | 0.71 | MGMT (0.39) | TAAR1TSHRLMNACYP2D6ADRA1D | |
| SCHEMBL570036 | 0.71 | TAAR1 (0.69) | TAAR1TERTTSHRLMNACYP2D6 | |
| SCHEMBL8112129 | 0.70 | ADRA1D (0.37) | TAAR1TSHRLMNACYP2D6ADRA1D | |
| Hydrochloric Acid SCHEMBL1846181 | 0.69 | TAAR1 (0.67) | TAAR1TERTTSHRLMNACYP2D6 | |
| SCHEMBL3529630 | 0.69 | TAAR1 (0.44) | TAAR1TSHRLMNAADRA1D | |
| SCHEMBL10364897 | 0.69 | TAAR1 (0.44) | TAAR1TERTTSHRLMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120328628-A1 | ANTIBODIES TO CONFORMATIONALLY TRAPPED PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-27 | — | — | US | disclosed |
| WO-2008006087-A2 | ANTIBODIES TO CONFORMATIONALLY TRAPPED PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-01-10 | — | — | WO | disclosed |
| US-6048878-A | Substituted piperidine derivatives as selective agonists of 5-HT receptors | MERCK SHARP & DOHME LTD. (GB) | 2000-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120328628-A1 | ANTIBODIES TO CONFORMATIONALLY TRAPPED PROTEINS | TRAP1, UACA, SSB | TAAR1 4727/4885TERT 3855/4885TSHR 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.